Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

A New CEO, a Revenue Beat and an Upgrade: NeoGenomics (NASDAQ:NEO) Has a Busy Day

NeoGenomics (NASDAQ:NEO), a cancer-diagnostics laboratory company that runs genetic and molecular tests for oncologists and hospitals, was one of the most-discussed names in the S&P SmallCap 600 on Tuesday, October 6. The stock swung during the session, and sources gave conflicting accounts of its …

Nitish Kishor | 07 October 2026

Neogen (NASDAQ:NEOG) Whiplash: Down in the Regular Session, Up After Hours on a Revenue Beat

Neogen (NASDAQ:NEOG), which sells testing kits and services that help food producers and animal-health customers detect contaminants, pathogens and residues, had a whiplash day on Tuesday, October 6. During the regular session the stock fell and closed around $12.21, as health care struggled across …

Nitish Kishor | 07 October 2026

Repligen's BioLife Deal Reshuffles a Small-Cap Index

Repligen (NASDAQ:RGEN), a supplier of equipment and consumables used to manufacture biologic drugs, stayed in focus on Tuesday, October 6, because of its agreement to acquire BioLife Solutions (NASDAQ:BLFS). Repligen is generally counted among S&P MidCap 400 companies, and its deal has had a …

Nitish Kishor | 07 October 2026

BioLife Solutions (NASDAQ:BLFS) Is Leaving a Small-Cap Index on a Takeover

BioLife Solutions (NASDAQ:BLFS), a supplier of products that help preserve cells and tissues for cell and gene therapy developers, is leaving the S&P SmallCap 600 because it is being acquired by Repligen (NASDAQ:RGEN). S&P Dow Jones Indices said Freshworks (NASDAQ:FRSH), the customer-service and IT …

Nitish Kishor | 07 October 2026

Life-Science Tools Sell Off, and Bruker (NASDAQ:BRKR) Is Caught in the Downdraft

Bruker (NASDAQ:BRKR), the maker of high-end scientific instruments such as mass spectrometers, nuclear magnetic resonance systems and X-ray tools used by research labs and drug companies, slid on Tuesday, October 6, and traded around $59.71. That made it one of the notable decliners in …

Nitish Kishor | 07 October 2026

Why Did Fortrea (NASDAQ:FTRE) Buck a Weak Day for Health Care?

Fortrea Holdings (NASDAQ:FTRE), which runs clinical trials and provides drug-development services for pharmaceutical and biotech companies, rocketed on Tuesday, October 6, and traded around $23.32. The move made it one of the strongest gainers in the S&P SmallCap 600.

Nitish Kishor | 07 October 2026

Azenta (NASDAQ:AZTA) Jumps Even as Its Life-Science Peers Sink

Azenta (NASDAQ:AZTA), which provides sample storage, sample management and genomic services to drug developers and research institutions, jumped on Tuesday, October 6, and traded around $46.19. The move made it one of the notable gainers in the S&P SmallCap 600.

Nitish Kishor | 07 October 2026

The Cigna Group (NYSE:CI) Climbs as the Health Sense Launch Extends a Rebound From the Investor Day Dip

● Cigna closed at $274.37 on Tuesday, October 6, up $3.08 or 1.14%, its third straight daily gain, beating the S&P 500's 0.58% rise.

Nitish Kishor | 07 October 2026

Why Did Oscar Health (NYSE:OSCR) Slip After a Sharp Jump With No New Company News?

● Oscar Health closed at $32.38 on Tuesday, October 6, down 0.12%, onVolumeof about 3.4 million shares after a 4.78% jump on October 5.

Nitish Kishor | 07 October 2026

UnitedHealth Group (NYSE:UNH) Stock: Health Care Was the Session's Only Losing Sector

UnitedHealth Group (NYSE:UNH), the largest US health insurer and a member of the Dow Jones Industrial Average, slipped on Tuesday, October 6, closing lower. An earlier intraday reading had shown the stock slightly higher, but it gave up that gain as the session wore …

Nitish Kishor | 07 October 2026
Support

Hi! How can we help you today?

Loading…